GO:0032090 Pyrin domain binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032090 (Pyrin domain binding) is a molecular function describing the selective binding of a protein to a Pyrin (PAAD/DAPIN) domain, a death-domain-fold protein-protein interaction module.
• Pyrin domain binding is best known for mediating assembly of the NLRP3 inflammasome, where homotypic PYD-PYD interactions nucleate ASC oligomerization and downstream caspase-1 activation.
• The NLRP3 PYD is not sufficient for activation alone; NEK7 binds the NLRP3 LRR and licenses inflammasome assembly, illustrating how Pyrin domain binding is regulated by accessory proteins.
• Post-translational modifications such as ZDHHC5-mediated palmitoylation of NLRP3 promote NLRP3-NEK7 interaction and inflammasome activation, showing that Pyrin domain binding is tuned by lipidation.
• Dysregulated Pyrin domain binding and NLRP3 inflammasome activity are implicated in cardiovascular disorders, Alzheimer's disease, vascular calcification and a broad range of inflammatory diseases.
• CRISPR knockout, point-mutation, knock-in and overexpression cell models are the core tools for dissecting which Pyrin domain interfaces are required for inflammasome assembly and disease phenotypes.
Description
Pyrin domain binding (GO:0032090) is a molecular function that describes the binding of a protein to a Pyrin domain, also known as a PAAD or DAPIN domain, a compact protein-protein interaction module that adopts the same fold as the Death domain. Because Pyrin domains are found in a large family of cytosolic innate immune sensors and adaptors, this binding activity is a central node in the assembly of oligomeric signaling platforms, most prominently the NLRP3 inflammasome. Researchers study Pyrin domain binding to understand how homotypic domain interactions convert soluble sensor proteins into supramolecular signaling complexes that activate inflammatory caspases.
Pyrin domain binding At A Glance
| GO ID | GO:0032090 |
|---|---|
| GO term | Pyrin domain binding |
| Ontology | molecular_function |
| Synonym | DAPIN domain binding; PAAD domain binding |
| Definition | Binding to a Pyrin (PAAD/DAPIN) domain, a protein-protein interaction domain that has the same fold as the Death domain |
| Major function | Mediates homotypic and heterotypic protein-protein interactions that nucleate inflammasome assembly and innate immune signaling |
| Representative proteins | NLRP3, ASC/PYCARD, NLRP1, AIM2, IFI16, MEFV/pyrin, NEK7 |
| Related disease areas | Cardiovascular disorders, Alzheimer's disease, vascular calcification, inflammatory diseases |
| Research methods | CRISPR KO/point mutation/knock-in, co-immunoprecipitation, inflammasome reconstitution, structural biology |
What Is GO:0032090?
In the Gene Ontology, Pyrin domain binding (GO:0032090) is defined as binding to a Pyrin (PAAD/DAPIN) domain, a protein-protein interaction domain that has the same fold as the Death domain. It is a molecular_function term with the synonyms DAPIN domain binding and PAAD domain binding. In practice, this term captures the selective, non-covalent interaction between a protein and a Pyrin domain, including the homotypic PYD-PYD contacts that drive inflammasome nucleation and the heterotypic contacts by which regulatory proteins engage Pyrin-domain-containing partners.
Why Is Pyrin domain binding Important in Cell Biology?
Pyrin domain binding is important because it is the molecular event that converts cytosolic pattern-recognition receptors into active signaling platforms. In the NLRP3 inflammasome, PYD-PYD interactions between NLRP3 and the adaptor ASC nucleate filament assembly and recruit caspase-1, which then drives maturation of IL-1beta and IL-18 and pyroptotic cell death. Because this binding step is required for inflammasome output, it is a focal point for understanding and therapeutically targeting inflammatory disease, including cardiovascular disorders and Alzheimer's disease.
• Defines the interaction module that nucleates NLRP3 inflammasome assembly through PYD-PYD contacts.
• Links innate immune sensing to caspase-1 activation and IL-1beta/IL-18 maturation.
• Is regulated by accessory proteins such as NEK7, which licenses NLRP3 activation.
• Is modulated by post-translational modification, including ZDHHC5-mediated NLRP3 palmitoylation.
• Contributes to cardiovascular pathology, including atherosclerosis-related inflammation and vascular calcification.
• Is implicated in neuroinflammation and Alzheimer's disease pathogenesis.
• Represents a druggable node for inflammatory disease therapy.
• Provides a mechanistic basis for interpreting disease-associated variants in Pyrin-domain-containing proteins.
• Enables reconstitution and structural studies of inflammasome nucleation.
• Supports CRISPR-based functional genomics of inflammasome signaling.
What Happens During Pyrin domain binding?
Priming and sensor engagement
In simple terms: The cell first gets a warning signal that raises the amount of the sensor protein before the inflammasome can be built.
Inflammasome activation typically requires a priming step that increases expression of NLRP3 and its partner proteins, after which a second signal triggers assembly. During this phase, the Pyrin domain of NLRP3 remains autoinhibited, and Pyrin domain binding is not yet productive.
Homotypic PYD-PYD nucleation
In simple terms: Two matching Pyrin domains stick together, starting a chain reaction that builds a large signaling platform.
Upon activation, the NLRP3 Pyrin domain engages the Pyrin domain of the adaptor ASC (PYCARD) through homotypic PYD-PYD interactions, nucleating ASC filament formation. This Pyrin domain binding event is the committed step that converts a soluble sensor into a supramolecular assembly platform.
NEK7-licensed assembly
In simple terms: A helper protein called NEK7 must hold the sensor in the right shape before the Pyrin domains can bind.
Structural and functional studies show that NEK7 binds the NLRP3 LRR domain and licenses NLRP3 inflammasome activation, a prerequisite for productive downstream Pyrin domain-dependent assembly. This illustrates that Pyrin domain binding does not occur in isolation but is gated by accessory protein contacts.
Palmitoylation-dependent regulation
In simple terms: A fat-like chemical tag added to the sensor helps it find its partner and turn on the inflammasome.
ZDHHC5-mediated palmitoylation of NLRP3 promotes the NLRP3-NEK7 interaction and inflammasome activation, providing a lipid-based layer of control over the assembly process that depends on Pyrin domain-mediated nucleation.
Caspase-1 activation and downstream output
In simple terms: Once the platform is built, it switches on an enzyme that cuts inflammatory messenger proteins into their active form.
ASC filaments recruit procaspase-1 via CARD-CARD interactions, leading to caspase-1 activation, cleavage of pro-IL-1beta and pro-IL-18, and pyroptosis. Thus, Pyrin domain binding is mechanistically upstream of the entire inflammatory output of the NLRP3 inflammasome.
Key Genes Involved in GO:0032090 Pyrin domain binding
The following genes and proteins are the principal players in Pyrin domain binding and its best-characterized signaling context, the NLRP3 inflammasome.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NLRP3 | Pyrin-domain-containing sensor that nucleates inflammasome assembly | Central target for inflammatory disease research and drug discovery |
| PYCARD (ASC) | Adaptor whose Pyrin domain binds NLRP3 PYD and whose CARD recruits caspase-1 | Essential for PYD-PYD nucleation and inflammasome reconstitution |
| NEK7 | Kinase that binds NLRP3 LRR and licenses activation | Required for NLRP3 inflammasome assembly and Pyrin domain-dependent signaling |
| ZDHHC5 | Palmitoyltransferase that modifies NLRP3 | Regulates NLRP3-NEK7 interaction and inflammasome activation |
| CASP1 | Effector caspase recruited downstream of Pyrin domain binding | Readout of inflammasome activation and IL-1beta maturation |
| IL1B | Cytokine processed by caspase-1 after inflammasome assembly | Biomarker of Pyrin domain-dependent inflammatory output |
| IL18 | Cytokine processed by caspase-1 after inflammasome assembly | Biomarker of inflammasome activation |
| NLRP1 | Pyrin-domain-containing sensor | Model for PYD-dependent inflammasome nucleation |
| AIM2 | PYD-containing DNA sensor | Illustrates PYD-ASC nucleation outside the NLR family |
| IFI16 | PYD-containing nuclear sensor | Context for Pyrin domain binding in innate immunity |
| MEFV (pyrin) | Pyrin-domain protein mutated in familial Mediterranean fever | Prototype of Pyrin domain biology |
| GSDMD | Pore-forming executioner of pyroptosis downstream of caspase-1 | Links Pyrin domain binding to cell death |
| NFKB1 | Transcription factor in priming of inflammasome components | Priming arm that precedes Pyrin domain binding |
| TXNIP | Redox protein implicated in NLRP3 activation | Context for upstream regulation of inflammasome assembly |
| SGT1 | Chaperone/co-chaperone in NLR biology | Model for accessory regulation of Pyrin-domain proteins |
| HSP90 | Chaperone stabilizing NLR proteins | Supports NLRP3 homeostasis prior to Pyrin domain binding |
How Is Pyrin domain binding Regulated?
Pyrin domain binding is regulated at multiple levels. Priming signals increase NLRP3 expression and poise the sensor for activation. NEK7 binding to the NLRP3 LRR is required to license inflammasome assembly, indicating that Pyrin domain-dependent nucleation is gated by accessory protein contacts. Post-translational modification adds another layer: ZDHHC5-mediated palmitoylation of NLRP3 promotes the NLRP3-NEK7 interaction and inflammasome activation. These regulatory inputs ensure that Pyrin domain binding and downstream caspase-1 activation occur only under appropriate inflammatory conditions.
Pyrin domain binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NLRP3 | Cardiovascular disorders and inflammation | NLRP3 knockout and point-mutation macrophages |
| NLRP3 | Vascular calcification | Canagliflozin-treated calcification model with NLRP3 perturbation |
| NLRP3 | Alzheimer's disease neuroinflammation | NLRP3 knockout microglia and neuronal co-culture |
| PYCARD (ASC) | Inflammasome assembly defects | ASC knockout reconstituted with PYD mutants |
| NEK7 | Licensing of inflammasome activation | NEK7 knockout with NLRP3 reconstitution |
Cardiovascular disorders and vascular calcification
NLRP3 inflammasome activity, which depends on Pyrin domain binding for assembly, has been implicated in cardiovascular disorders including atherosclerosis-related inflammation. In vascular calcification models, the SGLT2 inhibitor canagliflozin alleviates calcification through suppression of the NLRP3 inflammasome, linking Pyrin domain-dependent assembly to vascular pathology.
Alzheimer's disease and neuroinflammation
The NLRP3 inflammasome has been implicated in Alzheimer's disease pathogenesis, where persistent inflammatory signaling contributes to neuronal dysfunction. Because Pyrin domain binding is required for NLRP3 inflammasome assembly, it represents a mechanistic node connecting innate immune activation to neurodegeneration.
Inflammatory disease therapy
Targeting the NLRP3 inflammasome is an active therapeutic strategy for inflammatory disease, and the Pyrin domain binding step is a key vulnerability in this pathway. Small-molecule and biologic approaches that interfere with inflammasome assembly are being explored across a range of inflammatory conditions.
From Pyrin domain binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is NLRP3 required for a given inflammatory phenotype? | NLRP3 knockout cell line or primary macrophages |
| Which PYD residue is required for ASC nucleation? | Point-mutation knock-in of NLRP3 or PYCARD PYD |
| Does a disease-associated variant alter Pyrin domain binding? | Knock-in of the variant with co-immunoprecipitation readout |
| Where does NLRP3 interact with NEK7 in cells? | Tagged knock-in of NLRP3 or NEK7 for imaging and proximity assays |
| Does increased NLRP3 dosage drive inflammation? | Overexpression of NLRP3 or its PYD in reporter cells |
| Does palmitoylation control inflammasome assembly? | ZDHHC5 knockout or overexpression with NLRP3 palmitoylation readout |
How to Study the Pyrin domain binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Co-immunoprecipitation | Physical interaction between Pyrin-domain proteins | Detecting NLRP3-ASC and NLRP3-NEK7 binding |
| ASC speck imaging | Inflammasome assembly in cells | Functional readout of Pyrin domain binding |
| Caspase-1 activity assay | Downstream inflammasome activation | Validating PYD-dependent signaling |
| IL-1beta ELISA | Mature cytokine release | Quantifying inflammatory output |
| Crosslinking / oligomerization gel | ASC polymerization state | Testing nucleation defects |
| CRISPR knockout screening | Genes required for inflammasome activation | Discovery of regulators of Pyrin domain binding |
| Structural biology (cryo-EM) | Atomic interfaces of PYD complexes | Mapping binding surfaces |
| Palmitoylation assay | Lipid modification of NLRP3 | Testing ZDHHC5-dependent regulation |
Co-immunoprecipitation and pull-down assays
Co-immunoprecipitation of NLRP3 with ASC or NEK7 is a standard approach to detect Pyrin domain-dependent interactions in lysates from stimulated cells. Recombinant PYD pull-down assays can isolate the contribution of the Pyrin domain itself from other domains.
Inflammasome reconstitution and oligomerization assays
Reconstitution of NLRP3, ASC and caspase-1 in cells or in vitro allows measurement of ASC speck formation and caspase-1 activation as functional readouts of Pyrin domain binding. Crosslinking and semi-denaturing gels can resolve oligomeric ASC species.
Structural biology and modeling
Structural studies of NLRP3-NEK7 complexes and PYD filaments provide atomic-level insight into the interfaces that mediate Pyrin domain binding. These structures guide mutagenesis of PYD surfaces to test binding requirements.
CRISPR functional genomics and cytokine readouts
CRISPR knockout screens combined with IL-1beta or caspase-1 readouts identify genes required for Pyrin domain-dependent inflammasome activation. Targeted knockouts of ZDHHC5 and NEK7 illustrate how specific regulators can be validated.
How CRISPR Can Be Used to Study GO:0032090 Pyrin domain binding
Knockout
CRISPR knockout of NLRP3, PYCARD, NEK7 or ZDHHC5 is used to test whether Pyrin domain-dependent inflammasome assembly is required for a given inflammatory phenotype. Knockout macrophages and monocytic cell lines provide clean backgrounds for reconstitution experiments.
Point Mutation
Point mutations in the NLRP3 or PYCARD Pyrin domain can be introduced to map the residues that mediate homotypic PYD-PYD binding. Such mutants distinguish binding-defective from signaling-defective alleles in inflammasome assays.
Knock-in
Knock-in of disease-associated variants or epitope tags into endogenous NLRP3 or NEK7 loci allows study of Pyrin domain binding at physiological expression levels. Tagged knock-ins support imaging and proximity labeling of inflammasome components.
Overexpression
Overexpression of NLRP3, its isolated PYD, or ASC is used to drive spontaneous inflammasome assembly and to test whether increased Pyrin domain dosage is sufficient for activation. Overexpression systems are also useful for biochemical purification of PYD complexes.
How EDITGENE Supports Pyrin domain binding Research
Researchers studying Pyrin domain binding-related genes often need to determine whether a candidate gene is causally involved in inflammasome assembly or is merely a bystander in an inflammatory response. Establishing causality requires precise genetic perturbation of the sensor, adaptor or regulator, followed by functional readouts such as ASC speck formation, caspase-1 activation and IL-1beta release.
Contact EDITGENE today to design your custom CRISPR model for Pyrin domain binding research.
Frequently Asked Questions About Pyrin domain binding
What is Pyrin domain binding?
Pyrin domain binding (GO:0032090) is a molecular function describing the binding of a protein to a Pyrin (PAAD/DAPIN) domain, a death-domain-fold module that mediates protein-protein interactions such as PYD-PYD contacts in inflammasome assembly.
What genes are involved in Pyrin domain binding?
Key genes include NLRP3, PYCARD (ASC), NEK7, ZDHHC5, CASP1, IL1B, IL18, NLRP1, AIM2, IFI16 and MEFV, all of which participate in Pyrin-domain-dependent inflammasome signaling.
What is the GO ID for Pyrin domain binding?
The Gene Ontology identifier for Pyrin domain binding is GO:0032090, a molecular_function term with synonyms DAPIN domain binding and PAAD domain binding.
How does Pyrin domain binding activate the NLRP3 inflammasome?
After priming, the NLRP3 Pyrin domain binds the ASC Pyrin domain through homotypic PYD-PYD interactions, nucleating ASC filaments that recruit caspase-1 and drive IL-1beta maturation.
What role does NEK7 play in Pyrin domain binding?
NEK7 binds the NLRP3 LRR domain and licenses inflammasome activation, acting as a required accessory factor upstream of productive Pyrin domain-dependent assembly.
Is Pyrin domain binding regulated by post-translational modification?
Yes. ZDHHC5-mediated palmitoylation of NLRP3 promotes the NLRP3-NEK7 interaction and inflammasome activation, adding a lipid-based layer of regulation.
Which diseases are linked to Pyrin domain binding and inflammasomes?
NLRP3 inflammasome activity has been implicated in cardiovascular disorders, vascular calcification, Alzheimer's disease and a broad range of inflammatory diseases.
How can I study Pyrin domain binding in the lab?
Common approaches include co-immunoprecipitation, ASC speck imaging, caspase-1 activity assays, IL-1beta ELISA, structural biology and CRISPR knockout or point-mutation models.
Can CRISPR knockout help identify regulators of Pyrin domain binding?
Yes. CRISPR knockout of NLRP3, PYCARD, NEK7 or ZDHHC5, and genome-wide screens with inflammasome readouts, can identify genes required for Pyrin domain-dependent activation.
What experimental models are best for Pyrin domain binding research?
Macrophage and monocytic cell lines with NLRP3 or ASC knockout, reconstituted with wild-type or mutant Pyrin domains, are widely used, alongside tagged knock-in lines for imaging and interaction studies.
Conclusion
Pyrin domain binding (GO:0032090) is a compact but pivotal molecular function that underlies assembly of the NLRP3 inflammasome and related innate immune signaling platforms. Its regulation by accessory proteins such as NEK7 and by post-translational modifications such as ZDHHC5-mediated palmitoylation makes it a rich area for mechanistic study. Because dysregulated Pyrin domain-dependent signaling is implicated in cardiovascular disease, vascular calcification, Alzheimer's disease and inflammatory disorders, it is an attractive target for both basic research and therapeutic development.
References
- 1. Chen A et al.. 2023. Sodium-glucose cotransporter 2 inhibitor canagliflozin alleviates vascular calcification through suppression of nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 inflammasome.. Cardiovasc Res 119(13):2368-2381 PMID: 37523743
- 2. Cabral JE et al.. 2025. Targeting the NLRP3 inflammasome for inflammatory disease therapy.. Trends Pharmacol Sci 46(6):503-519 PMID: 40374417
- 3. Jo EK et al.. 2016. Molecular mechanisms regulating NLRP3 inflammasome activation.. Cell Mol Immunol 13(2):148-59 PMID: 26549800
- 4. He Y et al.. 2016. Mechanism and Regulation of NLRP3 Inflammasome Activation.. Trends Biochem Sci 41(12):1012-1021 PMID: 27669650
- 5. Zheng S et al.. 2023. ZDHHC5-mediated NLRP3 palmitoylation promotes NLRP3-NEK7 interaction and inflammasome activation.. Mol Cell 83(24):4570-4585.e7 PMID: 38092000
- 6. Wang Z et al.. 2018. Targeting NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome in Cardiovascular Disorders.. Arterioscler Thromb Vasc Biol 38(12):2765-2779 PMID: 30571177
- 7. Sharif H et al.. 2019. Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome.. Nature 570(7761):338-343 PMID: 31189953
- 8. Feng YY et al.. 2021. [Nucleotide-binding Oligomerization Domain-like Receptor Family Pyrin Domain Containing 3 Inflammasome in Alzheimer's Disease].. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 43(5):788-795 PMID: 34728041
